| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 100% | 17/17 |
| Female | 0% | 0/17 |
| Indifferent | 0% | 0/17 |
| Unknown | 0% | 0/17 |
| General | ||
| 17.6% | 3/17 | |
| 23.5% | 4/17 | |
| 11.8% | 2/17 | |
| 29.4% | 5/17 | |
| 29.4% | 5/17 | |
| 11.8% | 2/17 | |
| 81.3% | 13/16 | |
| 81.3% | 13/16 | |
| 88.2% | 15/17 | |
| 80% | 12/15 | |
| Neurology | ||
| 88.2% | 15/17 | |
| 70.6% | 12/17 | |
| 47.1% | 8/17 | |
| Facial abnormalities | ||
| 70.6% | 12/17 | |
| 52.9% | 9/17 | |
| 35.3% | 6/17 | |
| 94.1% | 16/17 | |
| Visual and hearing impairments | ||
| 17.6% | 3/17 | |
| 35.3% | 6/17 | |
| Heart | ||
| 11.8% | 2/17 | |
| Gastrointestinal | ||
| 23.5% | 4/17 | |
| Urogenital | ||
| 47.1% | 8/17 | |
| Skeleton | ||
| 100% | 17/17 | |
| Skin / Hair / Nails | ||
| 47.1% | 8/17 | |
| Endocrine / Immunological / Metabolic | ||
| 23.5% | 4/17 | |
| 17.6% | 3/17 | |
| 23.5% | 4/17 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/17 |
| Inheritance | ||
| 100% | 17/17 | |
SMS